| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.1M | — |
| SG&A Expense | $414K | -97.9% |
| Operating Income | -$414K | +97.2% |
| Interest Expense | $81 | -15.6% |
| Pre-tax Income | -$414K | +97.1% |
| Income Tax | $328K | -74.7% |
| Net Income | -$30.8M | -14.3% |
| EPS (Basic) | -$20.13 | -2860.3% |
| EPS (Diluted) | -$20.13 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $389K | -97.3% |
| Accounts Receivable | $195K | — |
| Current Assets | $1.6M | -89.9% |
| Total Assets | $3.8M | -92.5% |
| Current Liabilities | $334K | -98.2% |
| Total Liabilities | $334K | -98.2% |
| Stockholders' Equity | $3.5M | -89.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$886K | +83.9% |
| Investing Cash Flow | -$12.5M | -883.4% |
| Financing Cash Flow | $23.1M | +1.3% |
| +1.1% |